Ataluren update - View News Article - Action Duchenne - Fighting for a cure for muscular dystrophy: "PTC Therapeutics is actively involved in preparations for initiating an open-label study for patients with nonsense mutation Duchenne/Becker muscular dystrophy previously treated with ataluren at sites outside the U.S. "
'via Blog this'
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment